compounded semaglutide crackdown news november 2025 FDA ESCALATES: 30 telehealth companies hit with warning letters for false claims on GLP-1 drugs. The agency accuses firms of misleading consumers by implying unapproved compounded versions match FDA-approved medications US judge upholds FDA's removal

According to FDA-approved labeling and clinical trial data, the following side effects occur most commonly: Gastrointestinal Effects: Nausea (affecting 1544% of patients, with higher rates at Wegovy doses) [3] [4] Diarrhea (reported in 830% of patients) Vomiting (524% incidence) Constipation (occurring in 324% of patients) Abdominal pain (520% of patients) These gastrointestinal symptoms typically emerge during dose escalation and often diminish with continued therapy as physiological adaptation occurs

She is a board-certified Family Nurse Practitioner dedicated to providing compassionate, high-quality, personalized, and culturally appropriate care for all patients

If you encounter mild or occasional discomfort, it may subside as your body adapts to the medication

How Does Tirzepatide Powder Compare to Semaglutide Powder in Mechanism